|
|
Volumn 29, Issue 2, 2010, Pages 155-158
|
|
How to meet national quality initiatives: Best practices
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
FONDAPARINUX;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
WARFARIN;
ACUTE CORONARY SYNDROME;
ANTICOAGULANT THERAPY;
CLINICAL PRACTICE;
CONFERENCE PAPER;
CONTINUOUS INFUSION;
CREATININE CLEARANCE;
DRUG EFFICACY;
DRUG SAFETY;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEALTH PROGRAM;
HEALTH SERVICE;
HEPARIN INDUCED THROMBOCYTOPENIA;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
PARTIAL THROMBOPLASTIN TIME;
PATIENT SAFETY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
VENOUS THROMBOEMBOLISM;
ACADEMIC MEDICAL CENTERS;
ADVISORY COMMITTEES;
ANTICOAGULANTS;
BENCHMARKING;
BOSTON;
CONSUMER PRODUCT SAFETY;
DRUG MONITORING;
EVIDENCE-BASED MEDICINE;
FIBRINOLYTIC AGENTS;
GUIDELINE ADHERENCE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
ORGANIZATIONAL OBJECTIVES;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PATIENT CARE TEAM;
PATIENT EDUCATION AS TOPIC;
PRACTICE GUIDELINES AS TOPIC;
PROGRAM DEVELOPMENT;
QUALITY INDICATORS, HEALTH CARE;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
|
EID: 77949913908
PISSN: 09295305
EISSN: None
Source Type: Journal
DOI: 10.1007/s11239-009-0406-3 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (4)
|
